Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
In: The BMJ
These trials involve large groups of people and include long-term studies to monitor side effects and ensure the drug performs as intended
Studies referenced across clinical literature show that semaglutide delivers up to 15 per cent body weight reduction, making it one of the most effective weight management therapies available
Clinical data from the SUSTAIN diabetes program and STEP obesity program showed low rates of ADA development (3-7% of patients across trials), with most ADAs being non-neutralizing and not associated with clinically meaningful reductions in efficacy
Li, Q, Wang, H, Xu, R, Su, Y, Zhu, W
US$ 20.42
US$ 24.71
US$ 28.76
US$ 20.39
